Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats

Brain Research

Volumn 827, Issue 1-2, 1999, Pages 160-168

  Pollack, Alexia E ^a   Strauss, Jonathan B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Apomorphine; c Fos; D2 dopamine receptor; NMDA glutamate receptor; Priming

Indexed keywords

APOMORPHINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; PROTEIN C FOS; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION; TIME;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NERVE DEGENERATION; OXIDOPAMINE; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; ROTATION; SYMPATHOLYTICS; TIME FACTORS;

EID: 0033535735     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01325-6     Document Type: Article

References (33)

1. Albin R.L., Young A.B., Penny J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. Asin K.E., Bednarz L., Nikkel A., Richard P. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa. J. Pharmacol. Exp. Ther. 273:1995;1483-1490.
3. Caracini T., Scigliano G., Musicco M. The occurrence of motor fluctuations in parkinsonian patients treated with long-term levodopa: role of early treatment and disease progression. Neurology. 41:1991;384-389.
4. Carey R.J. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res. 568:1991;205-214.
5. Crocker S.J., Morelli M., Wigle N., Nakabeppu Y., Robertson G.S. D1-receptor-related priming is attenuated by anti-sense mediated 'knockdown' of fosB expression. Mol. Brain Res. 53:1998;69-77.
6. Dragunow M., Butterworth N., Waldvogel H., Faull R.L.M., Nicholson L.F.B. Prolonged expression of Fos-related antigens, Jun B and TrkB in dopamine-denervated striatal neurons. Mol. Brain Res. 30:1995;393-396.
7. Dragunow M., Leah J.D., Faull R.L.M. Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta. Mol. Brain Res. 10:1991;355-358.
8. Dragunow M., Robertson G.S., Faull R.L.M., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce Fos and related proteins in striatal neurons. Neuroscience. 37:1990;287-294.
9. Engber T.M., Susel Z., Juncos J.L., Chase T.N. Continuous and intermittent levodopa differentially affect rotation induced by D1 and D2 dopamine agonists. Eur. J. Pharmacol. 169:1989;291-298.
10. Gancher S., Mayer A. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response. Brain Res. 682:1995;63-68.
11. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
12. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1 and D2 dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
13. Harrison M.B., Wiley R.G., Wooten G.F. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res. 590:1992;305-310.
14. Jian M., Staines W.A., Iadorola M.J., Robertson G.S. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Mol. Brain Res. 19:1993;156-160.
15. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
16. Marsden C.D., Parkes J.D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet. 1:1977;345-349.
17. Morelli M., Di Chiara G. Agonist-induced homologous and heterologous sensitization to D1- and D2-dependent contraversive turning. Eur. J. Pharmacol. 141:1987;101-107.
18. Morelli M., Di Chiara G. Stereospecific blockade of N-methyl-D-aspartate transmission by MK-801 prevents priming of SKF 38393-induced turning. Psychopharmacology. 101:1990;287-288.
19. Morelli M., Fenu S., Carta A., Di Chiara G. Effect of MK-801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate putamen. Behav. Brain Res. 79:1996;93-100.
20. Morelli M., Fenu S., Garau L., Di Chiara G. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur. J. Pharmacol. 162:1989;329-335.
21. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
22. Paul M.L., Currie R.W., Robertson H.A. Priming of a D1 dopamine receptor behavioral response is dissociated from striatal immediate early gene activity. Neuroscience. 66:1995;347-359.
23. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, CA, 1986.
24. Pollack A.E., Turgeon S.M., Fink J.S. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Neuroscience. 79:1997;79-93.
25. A.E. Pollack, T.M. Yates, Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine lesioned rats, submitted.
26. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
27. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
28. Rouillard C., Bedard P., Falardeau P., Di Paolo T. Repeated stimulation of D1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Eur. J. Pharmacol. 157:1988;125-133.
29. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
30. Sheng M., Greenberg M.E. The regulation of function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
31. Starr M.S. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse. 19:1995;264-293.
32. Vallone D., Pellecchia M.T., Morelli M., Verde P., DiChiara G., Barone P. Behavioral sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. Mol. Brain Res. 52:1997;307-317.
33. Wachtel H., Kunow M., Loschmann P.A. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neurosci. Lett. 142:1992;179-182.